The ureteroscope market size was valued at USD 1.34 billion in 2025 and estimated to grow from USD 1.42 billion in 2026 to reach USD 1.87 billion by 2031, at a CAGR of 5.75% during the forecast period (2026-2031). This report is Segmented by Product (Flexible Ureteroscopes and Semi-Rigid Ureteroscopes), Usability (Single-Use/Disposable Ureteroscopes and Reusable Ureteroscopes), Application (Urolithiasis, and More), End User (Hospitals, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).
Manufacturers now differentiate through software rather than optics alone. Boston Scientific’s pressure-monitoring layer and Olympus’s EDOF imaging illustrate value-add pathways that influence tender outcomes. Meta-audits show a generational decline in shaft diameter correlating with fewer ureteral dilations and shorter hospital stays, fostering healthy replacement timelines across the ureteroscope market.
Reusable scopes retain 70.85% share because high-volume centers amortize capital quickly and value established reprocessing protocols. Yet single-use devices expand at a 9.78% CAGR, propelled by data linking disposables to lower post-operative infection rates and zero repair downtime. Portable form factors allow ASCs lacking autoclaves to perform advanced lithotripsy, widening ureteroscope market size in decentralized corridors.
Cost divides opinion: 59.11% of urologists cite price as the prime barrier, but total-cost-of-ownership studies show parity once repair, sterilization labor, and scope loss are tallied. Optical parity debates have subsided; LithoVue Elite’s 270° deflection and full-HD sensor now match many reusable benchmarks, smoothing adoption curves.
Europe ranks second. Single-use uptake is brisk in the United Kingdom and Germany; conversely, Scandinavian buyers weigh environmental metrics, tempering disposable growth. Southern and Eastern Europe unlock latent demand via modernization funds, broadening ureteroscope market presence across the continent.
Asia-Pacific is the fastest-growing region at a 6.85% CAGR through 2031. China’s centralized value-based procurement compresses pricing yet drives bulk orders; Japan and South Korea adopt ultra-slim digital scopes early, while India’s private-hospital boom fuels volume growth. Divergent price tiers oblige suppliers to tailor portfolios, enlarging ureteroscope market size across both premium and cost-sensitive segments.
Global Ureteroscopes Market Trends and Insights
Rising Global Burden of Urolithiasis & Related Urological Disorders
Kidney-stone incidence hit 106 million cases in 2021 and continues to climb, providing a constant pipeline of candidates for endoscopic stone removal. The gender gap narrows each year; U.S. prevalence among women rose from 6.5% in 2007-2008 to 9.1% in 2017-2020, prompting vendors to refine ergonomics that suit broader anatomies. Regional dynamics vary: Eastern Europe and Central Asia register rising case loads, whereas several East-Asian nations report modest declines, steering sales targets accordingly. Pediatric stone disease, exceeding 3 million annual cases, fuels demand for ultra-miniature shafts that limit ureteral trauma, underpinning long-term growth in the ureteroscope market.Shift Toward Minimally Invasive Stone-Management Procedures
European Association of Urology guidelines now recommend ureteroscopy ahead of shock-wave therapy for stones under 20 mm, citing stone-free rates between 81%-94%. Same-day discharge cuts facility costs and boosts ASC throughput, while machine-learning algorithms streamline case selection, reducing intra-operative surprises. Combined, these factors enlarge procedural volume, reinforcing expansion of the ureteroscope market.High Acquisition & Maintenance Cost of Digital Ureteroscopes
A modern digital flexible scope often exceeds USD 20,000 and carries USD 6,000-8,000 in annual service, deterring cash-strapped hospitals. Although disposables bypass repair bills, their per-procedure expense can outstrip local tariffs in emerging economies, slowing uptake and tempering ureteroscope market expansion.Other drivers and restraints analyzed in the detailed report include:
- Advancements in Digital Flexible & Single-Use Ureteroscope Technology
- Increasing Healthcare Spending & Reimbursement Support for Endourology
- Environmental & Waste-Management Concerns over Disposable Scopes
Segment Analysis
Flexible designs held 57.68% of the ureteroscope market in 2025, buoyed by pixel-dense sensors that boost calyceal visualization and ultra-slim 7.5 Fr shafts that ease access without prior dilation. A multicenter study published in May 2025 comparing a 6.3 Fr and 7.5 Fr disposable scope logged stone-free rates of 95% and 92.9%, respectively, and shaved operative time by 4.5 minutes with the smaller device. Semi-rigid systems, prized for durability, grow at 8.89% CAGR because budget-sensitive hospitals regard them as a low-risk entry point, subtly lifting overall ureteroscope market size.Manufacturers now differentiate through software rather than optics alone. Boston Scientific’s pressure-monitoring layer and Olympus’s EDOF imaging illustrate value-add pathways that influence tender outcomes. Meta-audits show a generational decline in shaft diameter correlating with fewer ureteral dilations and shorter hospital stays, fostering healthy replacement timelines across the ureteroscope market.
Reusable scopes retain 70.85% share because high-volume centers amortize capital quickly and value established reprocessing protocols. Yet single-use devices expand at a 9.78% CAGR, propelled by data linking disposables to lower post-operative infection rates and zero repair downtime. Portable form factors allow ASCs lacking autoclaves to perform advanced lithotripsy, widening ureteroscope market size in decentralized corridors.
Cost divides opinion: 59.11% of urologists cite price as the prime barrier, but total-cost-of-ownership studies show parity once repair, sterilization labor, and scope loss are tallied. Optical parity debates have subsided; LithoVue Elite’s 270° deflection and full-HD sensor now match many reusable benchmarks, smoothing adoption curves.
Complete Report Scope:
- By Product
- Flexible Ureteroscopes
- Digital Flexible Ureteroscopes
- Fiber-optic Flexible Ureteroscopes
- Semi-Rigid Ureteroscopes
- Flexible Ureteroscopes
- By Usability
- Single-Use / Disposable Ureteroscopes
- Reusable Ureteroscopes
- By Application
- Urolithiasis
- Kidney Cancer
- Urinary Stricture
- Other Applications
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Other End Users
- Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America retained a 37.75% share of the ureteroscope market in 2025, fueled by 9.25% kidney-stone prevalence among U.S. adults and broad coverage for digital scopes. The 2025 outpatient payment bump bolsters ROI, encouraging both academic hospitals and ASCs to refresh fleets. Realtime pressure-monitoring models such as LithoVue Elite help manage complex cases, cementing premium-product demand.Europe ranks second. Single-use uptake is brisk in the United Kingdom and Germany; conversely, Scandinavian buyers weigh environmental metrics, tempering disposable growth. Southern and Eastern Europe unlock latent demand via modernization funds, broadening ureteroscope market presence across the continent.
Asia-Pacific is the fastest-growing region at a 6.85% CAGR through 2031. China’s centralized value-based procurement compresses pricing yet drives bulk orders; Japan and South Korea adopt ultra-slim digital scopes early, while India’s private-hospital boom fuels volume growth. Divergent price tiers oblige suppliers to tailor portfolios, enlarging ureteroscope market size across both premium and cost-sensitive segments.
List of Companies Covered in this Report:
- Olympus
- Boston Scientific
- Stryker
- Karl Storz
- Richard Wolf
- PENTAX Medical (Hoya Corp.)
- Dornier MedTech
- EMS Electro Medical Systems S.A.
- Cook Group
- Vimex
- Elmed Medical Industry & Trade Inc.
- Opcom Inc.
- AED.MD, Inc.
- Prosurg
- Coloplast
- Pusen Medical
- OTU Medical
- Zhuhai Kangji Medical
- Urotech GmbH
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 Introduction
4 Market Landscape
5 Market Size & Growth Forecasts (Value, USD)
6 Competitive Landscape
7 Market Opportunities & Future Outlook
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Olympus Corporation
- Boston Scientific Corporation
- Stryker Corporation
- Karl Storz SE & Co. KG
- Richard Wolf GmbH
- PENTAX Medical (Hoya Corp.)
- Dornier MedTech
- EMS Electro Medical Systems S.A.
- Cook Medical LLC
- Vimex Sp. z o.o.
- Elmed Medical Industry & Trade Inc.
- Opcom Inc.
- AED.MD, Inc.
- Prosurg Inc.
- Coloplast A/S
- Pusen Medical
- OTU Medical
- Zhuhai Kangji Medical
- Urotech GmbH
